The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era

Y Moayedi1, L K Truby2, F Foroutan1

  • 1Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Ontario, Canada.

PubMed

Insights

Primary graft dysfunction (PGD) after heart transplantation is increasing. Preoperative dialysis, LVAD support, and longer ischemic times are key risk factors for severe PGD, impacting survival.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Primary graft dysfunction (PGD) is a major cause of early morbidity and mortality following heart transplantation (HT).
  • The International Consortium on PGD aims to identify contemporary clinical risk factors for PGD.
  • This study assesses PGD incidence, evaluates the RADIAL score, and redefines risk factors in current HT practices.

Purpose of the Study:

  • To assess the incidence of severe PGD in an international heart transplant cohort.
  • To evaluate the performance of the RADIAL score in predicting severe PGD.
  • To identify and redefine contemporary clinical risk factors for severe PGD.

Main Methods:

  • Retrospective, observational study of 2746 adult HT recipients from 2010-2020 across 10 international centers.
  • Comparison of patients with severe PGD versus those without severe PGD.
  • Multivariable mixed-effects logistic regression to identify risk factors, accounting for center variability.

Main Results:

  • Severe PGD occurred in 7.8% of patients, with an increasing incidence over the study period.
  • The RADIAL score demonstrated poor performance (AUC 0.53) in this contemporary cohort.
  • Acute preoperative dialysis, durable LVAD support, and total ischemic time were associated with increased severe PGD risk.

Conclusions:

  • The incidence of PGD is rising in the modern heart transplant era.
  • Contemporary risk factors for severe PGD have been identified, highlighting significant mortality risk.
  • These findings can inform management strategies to identify and mitigate PGD risk in high-risk patients.
Abstract